Abstract

This paper addresses the critical issue of perinatal substance use (PSU) in Canada and highlights the urgent need for relevant and current prevalence data. PSU poses significant risks to perinatal and infant health, highlighting the need for targeted interventions that are grounded in comprehensive data and research. Comprehensive data collection must include disaggregated information by province and differentiate between various substances. Nurse leaders are uniquely positioned to advocate for these initiatives, enhance healthcare provider education and support ongoing research. A coordinated approach is essential for improving health outcomes for perinatal individuals and their families across Canada.